白细胞介素-10：特发性肺纤维化的另一个治疗靶点？
IL-10: Another therapeutic target in idiopathic pulmonary fibrosis?
作者信息
Millar A B
出版信息
Thorax. 2006 Oct;61(10):835-6. doi: 10.1136/thx.2006.060772.
Abstract
The need for appropriately designed clinical trials in IPF
摘要
特发性肺纤维化（IPF）中对设计合理的临床试验的需求
相似文献
1
IL-10: Another therapeutic target in idiopathic pulmonary fibrosis?白细胞介素-10：特发性肺纤维化的另一个治疗靶点？
Thorax. 2006 Oct;61(10):835-6. doi: 10.1136/thx.2006.060772.
2
Therapeutics targeting IL-13 for the treatment of pulmonary inflammation and airway remodeling.靶向白细胞介素-13治疗肺部炎症和气道重塑的疗法。
Curr Opin Investig Drugs. 2008 Nov;9(11):1180-4.
3
Antifibrotic action of pirfenidone and prednisolone: different effects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosis.吡非尼酮和泼尼松龙的抗纤维化作用：对博来霉素诱导的小鼠肺纤维化中肺细胞因子和生长因子的不同影响
Eur J Pharmacol. 2008 Aug 20;590(1-3):400-8. doi: 10.1016/j.ejphar.2008.06.046. Epub 2008 Jun 16.
4
[Antioxidative treatment of idiopathic pulmonary fibrosis].[特发性肺纤维化的抗氧化治疗]
Pneumologie. 2006 Jun;60(6):373-5. doi: 10.1055/s-2006-932209.
5
Optimal treatment for idiopathic pulmonary fibrosis.特发性肺纤维化的最佳治疗方法。
Thorax. 2008 Dec;63(12):1120-1; author reply 1121.
6
Thalidomide inhibits the intractable cough of idiopathic pulmonary fibrosis.沙利度胺可抑制特发性肺纤维化的顽固性咳嗽。
Thorax. 2008 Aug;63(8):749. doi: 10.1136/thx.2008.098699.
7
Role of interleukin-13 in cancer, pulmonary fibrosis, and other T(H)2-type diseases.白细胞介素-13在癌症、肺纤维化及其他2型辅助性T细胞（TH2）相关疾病中的作用。
Vitam Horm. 2006;74:479-504. doi: 10.1016/S0083-6729(06)74019-5.
8
[INSPIRE: Multinational study on the effectivity of interferon-gamma1b in idiopathic fibrosis of the lung].[激励：干扰素γ1b治疗特发性肺纤维化有效性的多国研究]
Pneumologie. 2005 Aug;59(8):568. doi: 10.1055/s-2005-870991.
9
Update on idiopathic pulmonary fibrosis: the role of gamma interferon and cytokines.特发性肺纤维化的最新进展：γ干扰素和细胞因子的作用
Med Health R I. 2007 Feb;90(2):43-5.
10
[Recent advances on the role of chemokines/chemokine receptors in the pathogenesis of idiopathic pulmonary fibrosis].趋化因子/趋化因子受体在特发性肺纤维化发病机制中的作用的最新进展
Recenti Prog Med. 2007 Feb;98(2):90-6.
引用本文的文献
1
IL-10 deficiency aggravates cell senescence and accelerates BLM-induced pulmonary fibrosis in aged mice via PTEN/AKT/ERK pathway.IL-10 缺乏通过 PTEN/AKT/ERK 通路加重衰老小鼠 BLM 诱导的肺纤维化中的细胞衰老。
BMC Pulm Med. 2024 Sep 11;24(1):443. doi: 10.1186/s12890-024-03260-x.
2
Botanical formulation HX110B ameliorates PPE-induced emphysema in mice via regulation of PPAR/RXR signaling pathway.植物配方 HX110B 通过调节 PPAR/RXR 信号通路改善 PPE 诱导的小鼠肺气肿。
PLoS One. 2024 Jul 25;19(7):e0305911. doi: 10.1371/journal.pone.0305911. eCollection 2024.
3
Network Pharmacology-Based Mechanistic Investigation of Jinshui Huanxian Formula Acting on Idiopathic Pulmonary Fibrosis.基于网络药理学的金水还鲜方治疗特发性肺纤维化的作用机制研究
Evid Based Complement Alternat Med. 2021 Jul 7;2021:8634705. doi: 10.1155/2021/8634705. eCollection 2021.
4
The role of Interleukin-10 and 13 in tuberculosis-associated pulmonary dysfunction.白细胞介素-10和13在结核病相关肺功能障碍中的作用。
Caspian J Intern Med. 2019 Spring;10(2):223-227. doi: 10.22088/cjim.10.2.223.
5
Prognosticating Outcomes in Interstitial Lung Disease by Mediastinal Lymph Node Assessment. An Observational Cohort Study with Independent Validation.通过纵隔淋巴结评估预测间质性肺疾病的预后。一项具有独立验证的观察性队列研究。
Am J Respir Crit Care Med. 2019 Mar 15;199(6):747-759. doi: 10.1164/rccm.201804-0761OC.
6
Pulmonary fibrosis: pathogenesis, etiology and regulation.肺纤维化：发病机制、病因及调控
Mucosal Immunol. 2009 Mar;2(2):103-21. doi: 10.1038/mi.2008.85. Epub 2009 Jan 7.
本文引用的文献
1
In vivo IL-10 gene delivery attenuates bleomycin induced pulmonary fibrosis by inhibiting the production and activation of TGF-beta in the lung.体内白细胞介素-10基因传递通过抑制肺中转化生长因子-β的产生和激活来减轻博来霉素诱导的肺纤维化。
Thorax. 2006 Oct;61(10):886-94. doi: 10.1136/thx.2005.056317. Epub 2006 Jun 29.
2
Mechanisms of immune suppression by interleukin-10 and transforming growth factor-beta: the role of T regulatory cells.白细胞介素-10和转化生长因子-β介导免疫抑制的机制：调节性T细胞的作用
Immunology. 2006 Apr;117(4):433-42. doi: 10.1111/j.1365-2567.2006.02321.x.
3
High-dose acetylcysteine in idiopathic pulmonary fibrosis.高剂量乙酰半胱氨酸治疗特发性肺纤维化
N Engl J Med. 2005 Nov 24;353(21):2229-42. doi: 10.1056/NEJMoa042976.
4
Lethal acute respiratory distress syndrome during anti-TNF-alpha therapy for rheumatoid arthritis.类风湿关节炎抗TNF-α治疗期间发生的致死性急性呼吸窘迫综合征
Clin Rheumatol. 2006 May;25(3):430-2. doi: 10.1007/s10067-005-0008-1. Epub 2005 Oct 1.
5
Synergy in cytokine and chemokine networks amplifies the inflammatory response.细胞因子和趋化因子网络中的协同作用会放大炎症反应。
Cytokine Growth Factor Rev. 2005 Dec;16(6):561-80. doi: 10.1016/j.cytogfr.2005.03.005. Epub 2005 Jul 14.
6
Cultured alveolar macrophages from patients with idiopathic pulmonary fibrosis (IPF) show dysregulation of lipopolysaccharide-induced tumor necrosis factor-alpha (TNF-alpha) and interleukin-10 (IL-10) inductions.来自特发性肺纤维化（IPF）患者的培养肺泡巨噬细胞显示出脂多糖诱导的肿瘤坏死因子-α（TNF-α）和白细胞介素-10（IL-10）诱导的失调。
Eur Cytokine Netw. 2005 Jan-Mar;16(1):5-16.
7
Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis.吡非尼酮治疗特发性肺纤维化患者的双盲、安慰剂对照试验。
Am J Respir Crit Care Med. 2005 May 1;171(9):1040-7. doi: 10.1164/rccm.200404-571OC. Epub 2005 Jan 21.
8
Differential expression of IL-10 receptor by epithelial cells and alveolar macrophages.上皮细胞和肺泡巨噬细胞中白细胞介素-10受体的差异表达。
Allergy. 2004 May;59(5):505-14. doi: 10.1111/j.1398-9995.2004.00455.x.
9
Idiopathic pulmonary fibrosis: pathogenesis and therapeutic approaches.特发性肺纤维化：发病机制与治疗方法
Drugs. 2004;64(4):405-30. doi: 10.2165/00003495-200464040-00005.
10
The role of transforming growth factor beta in lung development and disease.转化生长因子β在肺发育和疾病中的作用。
Chest. 2004 Feb;125(2):754-65. doi: 10.1378/chest.125.2.754.
Zotero 插件